Anúncio
Anúncio
IBIO
iBio, Inc. Common Stock
2.69
USDPatrocinado
+0.34
+14.38%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
2.67
-0.02
-0.86%
Relatórios de Lucros IBIO
Rácio de surpresa positiva
IBIO separação 7 de 17 últimas estimativas.
41%
Próximo Relatório
Data do Próximo Relatório
09 de fev. de 2026
Estimate for Q2 26 (Revenue/ EPS)
$34.00K
/-$0.09
Mudanças implicadas de Q1 26 (Revenue/ EPS)
-66.00%
/-18.18%
Mudanças implicadas de Q2 25 (Revenue/ EPS)
-83.00%
/-81.25%
iBio, Inc. Common Stock earnings per share and revenue
On 12 de nov. de 2025, IBIO reported earnings of -0.11 USD per share (EPS) for Q1 26, missing the estimate of -0.10 USD, resulting in a -5.16% surprise. Revenue reached 100.00 mil, compared to an expected 25.50 mil, with a 292.16% difference. The market reacted with a -8.00% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analistas forecast an EPS of -0.09 USD, with revenue projected to reach 34.00 mil USD, implying an diminuir of -18.18% EPS, and diminuir of -66.00% in Revenue from the last quarter.
FAQ
What were iBio, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, iBio, Inc. Common Stock reported EPS of -$0.11, missing estimates by -5.16%, and revenue of $100.00K, 292.16% above expectations.
How did the market react to iBio, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -8%, changed from $1.25 before the earnings release to $1.15 the day after.
When is iBio, Inc. Common Stock expected to report next?
The next earning report is scheduled for 09 de fev. de 2026.
What are the forecasts for iBio, Inc. Common Stock's next earnings report?
Based on 6
analistas, iBio, Inc. Common Stock is expected to report EPS of -$0.09 and revenue of $34.00K for Q2 2026.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio